We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GES
3276
DELISTED
Guess Inc
GES
$84K ﹤0.01%
7,177
+4,930
+219% +$56.7K
NOK icon
3277
Nokia
NOK
$59.3B
$84K ﹤0.01%
21,365
+20,579
+2,618% +$92.6K
PETS icon
3278
PetMed Express
PETS
$40M
$84K ﹤0.01%
2,639
+994
+60% +$32.9K
RITM icon
3279
Rithm Capital
RITM
$5.8B
$84K ﹤0.01%
10,487
-44,066
-81% -$339K
RVP icon
3280
Retractable Technologies
RVP
$20.4M
$84K ﹤0.01%
12,642
+11,991
+1,842% +$95.3K
SRG
3281
Seritage Growth Properties
SRG
$128M
$84K ﹤0.01%
6,256
+2,592
+71% +$31.7K
ACCD
3282
DELISTED
Accolade Inc
ACCD
$84K ﹤0.01%
+2,162
New +$74.5K
CALB
3283
DELISTED
California BanCorp Common Stock
CALB
$84K ﹤0.01%
7,437
-3,144
-30% -$40.6K
ICPT
3284
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$84K ﹤0.01%
2,018
-1,938
-49% -$89K
TCF
3285
DELISTED
TCF Financial Corporation Common Stock
TCF
$84K ﹤0.01%
3,603
-27,127
-88% -$726K
DNLI icon
3286
Denali Therapeutics
DNLI
$3.89B
$83K ﹤0.01%
2,306
-7,275
-76% -$219K
GH icon
3287
Guardant Health
GH
$21.2B
$83K ﹤0.01%
741
+526
+245% +$48.1K
RMTI icon
3288
Rockwell Medical
RMTI
$29.6M
$83K ﹤0.01%
703
+573
+441% +$99.1K
TALO icon
3289
Talos Energy
TALO
$2.62B
$83K ﹤0.01%
12,746
+9,941
+354% +$72.9K
PACW
3290
DELISTED
PacWest Bancorp
PACW
$83K ﹤0.01%
4,844
-9,038
-65% -$168K
SAL
3291
DELISTED
Salisbury Bancorp, Inc.
SAL
$83K ﹤0.01%
5,264
+5,024
+2,093% +$91.7K
TBIO
3292
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$83K ﹤0.01%
6,114
-7,775
-56% -$120K
FIVN icon
3293
FIVE9
FIVN
$2.47B
$82K ﹤0.01%
635
-7,509
-92% -$903K
IAG icon
3294
IAMGOLD
IAG
$10.5B
$82K ﹤0.01%
21,318
-6,187
-22% -$26.9K
MSBI icon
3295
Midland States Bancorp
MSBI
$693M
$82K ﹤0.01%
6,398
+2,826
+79% +$40.3K
OPBK icon
3296
OP Bancorp
OPBK
$234M
$82K ﹤0.01%
14,324
+11,335
+379% +$71.1K
ORGO icon
3297
Organogenesis Holdings
ORGO
$229M
$82K ﹤0.01%
21,520
+16,303
+312% +$64.4K
PAA icon
3298
Plains All American Pipeline
PAA
$16.7B
$82K ﹤0.01%
+13,678
New +$102K
WRAP icon
3299
Wrap Technologies
WRAP
$99.7M
$82K ﹤0.01%
12,077
+9,978
+475% +$95.1K
PTRS
3300
DELISTED
Partners Bancorp Common Stock
PTRS
$82K ﹤0.01%
14,604
+14,110
+2,856% +$85K
130 131
132
133 134

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.